Published in J Exp Med on October 01, 1985
Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med (1998) 1.47
Evasion of immunity to Plasmodium falciparum malaria by IgM masking of protective IgG epitopes in infected erythrocyte surface-exposed PfEMP1. Proc Natl Acad Sci U S A (2011) 1.24
Identification of residues in the Cmu4 domain of polymeric IgM essential for interaction with Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). J Immunol (2008) 1.12
Activation of phospholipase C in human B cells is dependent on tyrosine phosphorylation. J Clin Invest (1991) 1.09
Regulation of resting and cycling human B lymphocytes via surface IgM and the accessory molecules interleukin-4, CD23 and CD40. Immunology (1989) 0.98
Structural requirements for the interaction of human IgM and IgA with the human Fcalpha/mu receptor. Eur J Immunol (2009) 0.93
Investigating the function of Fc-specific binding of IgM to Plasmodium falciparum erythrocyte membrane protein 1 mediating erythrocyte rosetting. Cell Microbiol (2015) 0.88
Novel evolved immunoglobulin (Ig)-binding molecules enhance the detection of IgM against hepatitis C virus. PLoS One (2011) 0.88
Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance. J Exp Med (1988) 0.82
Soluble, but not immobilized, anti-IgM antibody inhibits post-activation events leading to T-cell-dependent B-cell differentiation. Immunology (1995) 0.75
Biochemical basis of synergy between antigen and T-helper (Th) cell-mediated activation of resting human B cells. J Clin Invest (1989) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry (1978) 22.56
STUDIES ON RABBIT LYMPHOCYTES IN VITRO. I. STIMULATION OF BLAST TRANSFORMATION WITH AN ANTIALLOTYPE SERUM. J Exp Med (1965) 8.81
Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells. Curr Top Microbiol Immunol (1978) 4.88
Antibody production by hybridomas. J Immunol Methods (1980) 3.32
Frequency of B lymphocytes responsive to anti-immunoglobulin. J Exp Med (1982) 3.30
Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies. J Immunol (1983) 3.26
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. J Immunol (1981) 3.02
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
Activation of mouse lymphocytes by anti-immunoglobulin. I. Parameters of the proliferative response. J Exp Med (1978) 2.86
T cell regulation of IgG subclass antibody production in response to T-independent antigens. J Exp Med (1981) 2.50
Differences in susceptibility of mature and immature mouse B lymphocytes to anti-immunoglobulin-induced immunoglobulin suppression in vitro. Possible implications for B-cell tolerance to self. J Exp Med (1975) 2.40
Monoclonal antibodies: purification, fragmentation and application to structural and functional studies of class I MHC antigens. J Immunol Methods (1982) 2.35
Differential sensitivity of human B cell subsets to activation signals delivered by anti-mu antibody and proliferative signals delivered by a monoclonal B cell growth factor. J Exp Med (1983) 2.34
Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci U S A (1976) 2.34
Inhibition of mitogenic stimulation of mouse lymphocytes by anti-mouse immunoglobulin antibodies. I. Mode of action. Eur J Immunol (1974) 2.33
Ia+ T cells in synovial fluid and tissues of patients with rheumatoid arthritis. Arthritis Rheum (1981) 2.30
Immortalized B lymphocytes produce B-cell growth factor. Nature (1984) 2.23
Stimulation of mouse lymphocytes by insoluble anti-mouse immunoglobulin. Nature (1975) 2.07
Stimulation of human B lymphocytes by antibodies to IgM and IgG: functional evidence for the expression of IgG on B-lymphocyte surface membranes. Clin Immunol Immunopathol (1980) 2.00
Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation. J Exp Med (1983) 1.69
Mixing two monoclonal antibodies yields enhanced affinity for antigen. J Immunol (1982) 1.61
Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium. J Immunol (1981) 1.61
Control of B-lymphocyte function. I. Inactivation of mitogenesis by interactions with surface immunoglobulin and Fc-receptor molecules. J Exp Med (1976) 1.59
Regulation of growth and proliferation in B cell subpopulations. Immunol Rev (1982) 1.59
Triggering mechanism of B lymphocytes. I. Effect of anti-immunoglobulin and enhancing soluble factor on differentiation and proliferation of B cells. J Immunol (1975) 1.53
Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies. J Immunol (1983) 1.50
B lymphocyte differentiation induced by lipopolysaccharide. III. Suppression of B cell maturation by anti-mouse immunoglobulin antibodies. J Immunol (1976) 1.47
Long-term culture and cloning of nontransformed human B lymphocytes. J Exp Med (1981) 1.39
Anti-immunoglobulin stimulation of murine lymphocytes. I. Age dependency of the proliferative response. J Immunol (1976) 1.39
Induction of resting B cells to DNA synthesis by soluble monoclonal anti-immunoglobulin. Eur J Immunol (1984) 1.38
Activation of mouse lymphocytes by anti-immunoglobulin. II. A thymus-independent response by a mature subset of B lymphocytes. J Exp Med (1978) 1.37
Regulation of murine B cells through surface immunoglobulin. I. Monoclonal anti-delta antibody that induces allotype-specific proliferation. J Exp Med (1980) 1.16
Human B cell activation and cell cycle progression: stimulation with anti-mu and Staphylococcus aureus Cowan strain I. Eur J Immunol (1984) 1.10
A mitogen for human B cells: anti-Ig coupled to polyacrylamide beads activates blood mononuclear cells independently of T cells. J Immunol (1982) 1.06
Monoclonal antibodies specific for murine IgM. II. Activation of B lymphocytes by monoclonal antibodies specific for the four constant domains of IgM. Eur J Immunol (1985) 1.01
Human B cell differentiation. IV. Effect of monoclonal anti-immunoglobulin M and D antibodies on B cell proliferation and differentiation induced by T cell factors. J Immunol (1983) 0.98
Anti-immunoglobulin stimulation of murine lymphocytes. V. Age-related decline in Fc receptor-mediated immunoregulation. J Immunol (1978) 0.95
Accessory cell requirement for anti-IgM-induced proliferation of B lymphocytes. Nature (1978) 0.91
Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation. J Immunol (1983) 0.91
Peptide map comparisons of similar serologically defined HLA-DR antigens isolated from different lymphoblastoid cell lines. Hum Immunol (1982) 0.88
Changes in conformation with loss of alloantigenic determinants of a histocompatibility antigen (HLA-B7) induced by monoclonal antibodies. J Immunol (1984) 0.84
Role of membrane structures in B-lymphocyte activation. The effect of binding anti-immunoglobulin, aggregated IgG and immune complexes. Immunology (1976) 0.82
The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells. Eur J Immunol (1982) 0.78
Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med (1990) 3.23
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
T cell regulation of IgG subclass antibody production in response to T-independent antigens. J Exp Med (1981) 2.50
The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. J Clin Invest (1973) 2.42
Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med (1991) 2.32
IL-12 receptor. II. Distribution and regulation of receptor expression. J Immunol (1992) 1.92
T cell regulation of immunoglobulin class expression in the antibody response to trinitrophenyl-ficoll. Evidence for T cell enhancement of the immunoglobulin class switch. J Exp Med (1982) 1.88
A sicca syndrome in HIV infection: association with HLA-DR5 and CD8 lymphocytosis. Lancet (1989) 1.80
Patterns of expression of human "Ia-like" antigens during the terminal stages of B cell development. J Immunol (1978) 1.76
The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med (1987) 1.73
B-cell alloantigen Ag 7a in multiple sclerosis. Lancet (1975) 1.67
Role of T lymphocytes in the response to TNP-AECM-Ficoll. J Immunol (1980) 1.66
A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5. Ann Intern Med (1990) 1.57
Up-regulation of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregation. J Clin Invest (1988) 1.42
Effect of intravascular volume expansion on renal function during prolonged CO2 pneumoperitoneum. Ann Surg (2000) 1.41
CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice. Proc Natl Acad Sci U S A (2001) 1.41
Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. J Biol Chem (1996) 1.37
Receptors for IgM on certain human B lymphocytes. J Immunol (1977) 1.37
Acquired congenital heart block. Pattern of maternal antibody response to biochemically defined antigens of the SSA/Ro-SSB/La system in neonatal lupus. J Clin Invest (1989) 1.36
Role of the thymus in directing the development of a subset of B lymphocytes. J Exp Med (1982) 1.32
Constitutive and induced phosphorylation of the alpha- and beta-chains of the CD11/CD18 leukocyte integrin family. Relationship to adhesion-dependent functions. J Immunol (1990) 1.32
Evidence for immune complexes involving anti-lymphocyte antibodies associated with hypocomplementaemia in chronic lymphocytic leukaemia (CLL). Clin Exp Immunol (1976) 1.31
Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2003) 1.27
Effective separation of the 52 kDa SSA/Ro polypeptide from the 48 kDa SSB/La polypeptide by altering conditions of polyacrylamide gel electrophoresis. J Immunol Methods (1990) 1.23
Surface expression of Gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic Lupus erythematosus. Clin Immunol Immunopathol (1988) 1.21
Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity. J Exp Med (1983) 1.21
The human HLA-DR antigens are encoded by multiple beta-chain loci. J Immunol (1982) 1.19
Biological function and distribution of human interleukin-12 receptor beta chain. Eur J Immunol (1996) 1.17
HLA-B35 is associated with accelerated progression to AIDS. J Acquir Immune Defic Syndr (1992) 1.15
Anti-immunoglobulin antibodies. I. Expression of cross-reactive idiotypes and Ir gene control of the response to IgG2a of the b allotype. J Exp Med (1980) 1.08
Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum (1998) 1.07
Tissue infiltration in a CD8 lymphocytosis syndrome associated with human immunodeficiency virus-1 infection has the phenotypic appearance of an antigenically driven response. J Clin Invest (1993) 1.07
Molecular localization of human class II MT2 and MT3 determinants. J Exp Med (1984) 1.05
Hypoimmunoglobulinemia with normal T cell function in female siblings. Clin Immunol Immunopathol (1977) 1.03
Immune response to a thymus-dependent form of B512 dextran requires the presence of Lyb-5+ lymphocytes. J Exp Med (1983) 1.03
Association of certain Ia allotypes with the occurrence of chronic lymphocytic leukemia. Recognition by a monoclonal anti-Ia reagent of a susceptibility determinant not in the DR series. J Exp Med (1982) 1.03
IgG subclass, IgE, and IgA anti-trinitrophenyl antibody production within trinitrophenyl-Ficoll-responsive B cell clones. Evidence in support of three distinct switching pathways. J Exp Med (1983) 1.02
Congenital complete heart block. A human model of passively acquired autoimmune injury. Arthritis Rheum (1990) 1.00
Structural relationships between the DR beta 1 and DR beta 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. J Immunol (1986) 0.98
Application of monoclonal antibodies to the characterization of cells eluted from human articular cartilage. Expression of Ia antigens in certain diseases and identification of an 85-kD cell surface molecule accumulated in the pericellular matrix. Arthritis Rheum (1983) 0.98
Two pathways of CD11b/CD18-mediated neutrophil aggregation with different involvement of protein kinase C-dependent phosphorylation. J Immunol (1990) 0.95
Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant (1998) 0.95
Evidence for the separate molecular expression of four distinct polymorphic Ia epitopes on cells of DR4 homozygous individuals. Hum Immunol (1984) 0.95
Sustained and distinctive patterns of gene activation in synovial fibroblasts and whole synovial tissue obtained from inflammatory synovitis. Scand J Immunol (1994) 0.95
Certain HLA-DR5 and -DR6 major histocompatibility complex class II alleles are associated with a CD8 lymphocytic host response to human immunodeficiency virus type 1 characterized by low lymphocyte viral strain heterogeneity and slow disease progression. Proc Natl Acad Sci U S A (1994) 0.94
Orthotopic liver transplantation for congenital biliary atresia. An 11-year, single-center experience. Ann Surg (1996) 0.93
A novel association of DQ alpha and DQ beta genes in the DRw10 haplotype. Determination of a DQw1 specificity by the DQ beta-chain. J Immunol (1989) 0.91
Diffuse infiltrative lymphocytosis syndrome: a disorder occurring in human immunodeficiency virus-1 infection that may present as a sicca syndrome. Rheum Dis Clin North Am (1992) 0.89
Complete congenital heart block: risk of occurrence and therapeutic approach to prevention. J Rheumatol (1988) 0.89
Identification of the DRw10 DR beta 1-chain allele as encoding a polymorphic class II major histocompatibility complex epitope otherwise restricted to DR beta 2 molecules of the DRw53 type. J Immunol (1988) 0.89
Stimulators and inhibitors of hepatic porphyrin formation in human sera. J Clin Invest (1974) 0.87
Deleterious effect of waiting time on renal transplant outcome. Transplant Proc (2001) 0.86
Differential expression of the small inducible cytokines GRO alpha and GRO beta by synovial fibroblasts in chronic arthritis: possible role in growth regulation. Cytokine (1994) 0.86
Association of susceptibility to certain hematopoietic malignancies with the presence of Ia allodeterminants distinct from the DR series; utility of monoclonal antibody reagents. Immunol Rev (1983) 0.85
Contrasting patterns of newer histocompatibility determinants in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 0.84
Grouping HLA-B locus serologic specificities according to shared structural motifs suggests that different peptide-anchoring pockets may have contrasting influences on the course of HIV-1 infection. Hum Immunol (1995) 0.83
An approach to the human immunodeficiency virus-positive patient with a spondyloarthropathic disease. Rheum Dis Clin North Am (1991) 0.83
Anti-IgM-mediated B cell signaling. Molecular analysis of ligand binding requisites for human B cell clonal expansion and tolerance. J Exp Med (1988) 0.82
Analysis of the domain specificity of various murine anti-human IgM monoclonal antibodies differing in human B lymphocyte signaling activity. Mol Immunol (1987) 0.82
Complement activation and vascular injury in systemic lupus erythematosus. J Rheumatol Suppl (1987) 0.82
Pretransplant systemic inflammation and acute rejection after renal transplantation. Transplantation (2000) 0.81
HLA-DS molecules and their relation to supertypic specificities. Hum Immunol (1983) 0.81
Interaction of mycophenolate mofetil and HLA matching on renal allograft survival. Transplantation (2001) 0.81
Membrane IgD and membrane IgM differ in capacity to transduce inhibitory signals within the same human B cell clonal populations. J Immunol (1989) 0.81
The germline and somatic genetic basis for rheumatoid arthritis. Curr Dir Autoimmun (1999) 0.81
Outcomes of pediatric living donor renal transplant after laparoscopic versus open donor nephrectomy. Transplant Proc (2002) 0.81
Monoclonal antibody 1a3 recognizes a monomorphic epitope unique to DQ molecules. Hum Immunol (1987) 0.81
Loss of suppressor T-cells in active inflammatory bowel disease. Gut (1984) 0.80
Methicillin-resistant Staphylococcus aureus infection in liver transplantation: a matched controlled study. Transplant Proc (2005) 0.80
Aspects of the spectrum, prevalence and disease susceptibility determinants of Reiter's syndrome and related disorders associated with HIV infection. Rheumatol Int (1989) 0.80
Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype. J Immunol (1986) 0.80
T cell regulation of immunoglobulin class expression in the B cell response to TNP-Ficoll: characterization of the T cell responsible for preferential enhancement of the IgG2a response. J Immunol (1984) 0.79
Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin. Transplantation (1996) 0.79
Complications following posterior pharyngeal flap surgery. Cleft Palate J (1973) 0.78
Successful surgical salvage of partial pancreatic allograft thrombosis. Transplant Proc (2003) 0.78
HMG-CoA reductase inhibitors pravastatin and simvastatin inhibit human B-lymphocyte activation. Transplant Proc (1998) 0.78
Orthotopic liver transplantation from a donor with a history of schistosomiasis. Transplant Proc (2003) 0.77
Is there a serological difference between men and women with primary biliary cirrhosis? Am J Gastroenterol (1999) 0.77
Identification, at the genomic level, of an HLA-DR restriction element for cloned antigen-specific T4 cells. J Exp Med (1985) 0.77
A monovalent C mu 4-specific ligand enhances the activation of human B cells by membrane IgM cross-linking ligands. Int Immunol (1995) 0.77
Inhibition of lymphocyte trapping by cell-free ascitic fluids cultivated in syngeneic mice. J Immunol (1975) 0.77
Genetic determination of susceptibility and severity in rheumatoid arthritis. Ann Intern Med (1992) 0.77
Estrogen enhances dietary cholesterol induction of saturated bile in the hamster. Gastroenterology (1978) 0.77
Use of a solid-phase 3H-radioimmunoassay for the measurement of immunoglobulin produced in short-term cultures of antibody-secreting cells. J Immunol Methods (1982) 0.77
Human leukemic B cell activation: functional consequence of membrane IgM interaction with anti-IgM ligand is an alterable cell characteristic. Blood (1987) 0.76
A retrospective study of hearing impairment in three groups of cleft palate patients. Cleft Palate J (1979) 0.76
DNA sequence analysis of the HLA-DRw12 allele. Hum Immunol (1989) 0.76
Psoriatic arthritis--an enthesopathy-based disorder? Comment on the article by McGonagle et al. Arthritis Rheum (2000) 0.75
Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope. J Clin Invest (1985) 0.75
Description of two new HLA-C alleles in a black South African population. Tissue Antigens (2007) 0.75
Pilot study of early corticosteroid elimination after pancreas transplantation. Transplant Proc (2005) 0.75
A prospective study on the reliability and cost effectiveness of preoperative ultrasound screening of the "marginal" liver donor. Transplantation (1996) 0.75